Final Glance: Biotechnology companies
AP - Wed Oct 15, 5:07PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)
Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 4:20PM CDT
Novavax (NVAX) initiates phase II study on RSV vaccine.
MDVN: 89.63 (-1.68), EBS: 20.89 (+0.97), GILD: 96.16 (-1.02), NVAX: 4.69 (+0.20)
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 12:59PM CDT
Will Gilead's new HCV combo treatment pick up share like Sovaldi and bring in multi-billion dollar sales for the company?
VRTX: 101.10 (-3.16), ALNY: 84.39 (+1.44), GILD: 96.16 (-1.02), SRPT: 20.91 (+2.00), AUXL: 30.41 (-0.46), AMGN: 130.90 (-1.30), ABBV: 54.63 (+0.50)
Midday Glance: Biotechnology companies
AP - Wed Oct 15, 12:17PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)
Should Gilead Sciences, inc. Fear Incoming Competition?
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 15, 12:17PM CDT
Gilead Sciences ' shares have tumbled more than 8% in the past week as investors digest the FDA approval of its second-generation hepatitis C drug Harvoni and the potential competitive threats from AbbVie and Bristol-Myers Squibb . ...
GILD: 96.16 (-1.02), ABBV: 54.63 (+0.50), BMY: 48.96 (+0.04)
Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 15, 12:00PM CDT
Investors should take a close look to healthcare ETFs following Johnson & Johnson earnings beat.
JNJ: 98.21 (+1.20), PPH: 58.58 (-1.27), IYH: 127.08 (-0.84), GILD: 96.16 (-1.02), ABBV: 54.63 (+0.50), XLV: 60.52 (-0.50)
Jim Cramer on Stocks and Investing: Why I Hate This Market
at The Street - Wed Oct 15, 10:21AM CDT
Because it’s completely hit or miss.
JNJ: 98.21 (+1.20), SWKS: 49.60 (+0.69), GILD: 96.16 (-1.02), DOW: 44.09 (+0.16)
Early Glance: Biotechnology companies
AP - Wed Oct 15, 9:46AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)
Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths
at The Street - Wed Oct 15, 8:35AM CDT
Some perspective on recent positive news, which nonetheless, caused Seattle Genetics and Gilead shares to fall.
SGEN: 33.33 (+1.37), GILD: 96.16 (-1.02)
Critical Alerts For Tesla Motors, Tekmira Pharmaceuticals, Gilead Sciences, 3D Systems and TASER International Released By InvestorsObserver
PR Newswire - Wed Oct 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for TSLA, TKMR, GILD, DDD and TASR.
TSLA: 229.70 (+2.64), GILD: 96.16 (-1.02), DDD: 41.27 (+0.25), TKMR: 23.90 (+0.30), TASR: 14.69 (+0.49)
'Fast Money' Recap: Now May Be the Time to Buy Energy Stocks
at The Street - Wed Oct 15, 4:00AM CDT
The trading panel discussed whether margin calls are weighing on the energy sector and which technology stocks to consider.
F: 13.62 (-0.16), SWKS: 49.60 (+0.69), AMGN: 130.90 (-1.30), SOXX: 76.42 (+0.36), INTC: 31.27 (-0.87), PANW: 97.43 (+3.18), JNPR: 19.13 (+0.36), COH: 35.54 (-0.08), EBAY: 50.24 (-0.35), GILD: 96.16 (-1.02), GWPH: 61.55 (-3.65), DPZ: 83.65 (-0.65), GOOGL: 540.73 (-7.96), CP: 187.12 (-1.57), MELI: 106.16 (-1.87), CSCO: 22.96 (-0.10), KING: 11.38 (+0.13)
J&J raises outlook on Q3 beat
at Investor's Business Daily - Tue Oct 14, 5:51PM CDT
The medical giant's earnings, ex items, rose 10% to $1.50 a share, beating analysts' estimates by 5 cents. Sales climbed 5% to $18.47 bil, $90 mil ahead of consensus. Johnson & Johnson (JNJ) raised its full-year EPS guidance to $5.92-$5.97, on the...
JNJ: 98.21 (+1.20), GILD: 96.16 (-1.02)
Gilead
at Investor's Business Daily - Tue Oct 14, 5:49PM CDT
Gilead (GILD) shares fell 4.2% to 97.18 as light sales of J&J's Olysio could imply that Sovaldi sales may also come in light. Comments by J&J executives that they will work to make Olysio accessible and competitive in light of the recent approval of...
GILD: 96.16 (-1.02)
Wall Street Ends Mixed; Airlines Soar As Oil Plunges
at Investor's Business Daily - Tue Oct 14, 4:09PM CDT
Stocks ended mixed Tuesday after trimming early gains. Volume crept higher. The Nasdaq rose 0.3%, the S&P 500 climbed 0.2%, and the Dow Jones industrial average slipped a fraction. Preliminary data showed that volume rose slightly on the NYSE and the...
NFLX: 448.59 (-0.53), SWKS: 49.60 (+0.69), GILD: 96.16 (-1.02), DAL: 32.38 (-0.41), DPZ: 83.65 (-0.65), BAC: 15.76 (-0.76), SCHW: 25.32 (+0.04), URI: 93.43 (+0.98), LUV: 30.02 (+0.02)
Citigroup and Domino's are big market movers
AP - Tue Oct 14, 3:38PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
CERS: 4.21 (+0.11), HD: 87.85 (-2.25), ATLS: 37.45 (+2.15), C: 49.68 (-1.79), CSX: 32.98 (+0.37), AWI: 45.72 (-0.33), JNJ: 98.21 (+1.20), ALCS: 0.41 (+0.03), AES: 12.84 (-0.37), JPM: 55.53 (-2.46), GILD: 96.16 (-1.02), AAL: 31.69 (+0.18), DPZ: 83.65 (-0.65), STO: 23.42 (-0.58), OUTR: 55.54 (+1.92)
Stocks Close Mixed, Surrendering Some Early Gains
at Investor's Business Daily - Tue Oct 14, 3:23PM CDT
Stocks could only manage a mixed close Tuesday after surrendering significant gains. The Nasdaq and S&P 500 rose 0.3% and 0.2%, respectively, while the Dow Jones industrial average closed down a fraction. Preliminary numbers show volume tracking...
LCI: 40.30 (-0.36), GILD: 96.16 (-1.02), ALXN: 160.73 (+1.27), CVX: 109.27 (-0.51)
Stocks Retain Gains As Market Finally Gets A Rally
at Investor's Business Daily - Tue Oct 14, 1:55PM CDT
Stocks held on to much of their gains going into the final hour of trading Tuesday en route to finishing up for the first day in four. The Nasdaq rose 0.5%; the S&P 500 climbed 0.4%; and the Dow Jones industrial average gained 0.3%. Volume was...
SWKS: 49.60 (+0.69), GILD: 96.16 (-1.02), C: 49.68 (-1.79), DPZ: 83.65 (-0.65), ATHM: 45.12 (+2.63)
Drug Analysts Mull End Of 'Double Irish' Loophole
at Investor's Business Daily - Tue Oct 14, 12:10PM CDT
Wall Street was scrambling to assess the impact on drug stocks of the closing of a tax loophole known as "double Irish," proposed by the Irish government Tuesday. The issue is a different one from the overall lower corporate tax rates in Ireland,...
ACT: 217.24 (-4.83), GILD: 96.16 (-1.02), LLY: 62.87 (-0.27)